For the year ending 2025-12-31, BLFS made $96,214K in revenue. -$4,595K in net income. Net profit margin of -4.78%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 96,214 | 82,254 | ||
| Cost of revenue | 34,096 | - | ||
| Gross profit | 62,118 | - | ||
| General and administrative | 45,520 | 40,541 | ||
| Sales and marketing | 9,850 | 9,610 | ||
| Research and development | 7,566 | 7,912 | ||
| Cost of revenue (exclusive of intangible assets amortization) | - | 24,502 | ||
| Ipr&d expense | 15,521 | - | ||
| Intangible asset amortization | 263 | 2,737 | ||
| Change in fair value of contingent consideration | 0 | - | ||
| Total operating expenses | 78,720 | 89,383 | ||
| Operating loss | -16,602 | -7,129 | ||
| Interest income (expense), net | 2,706 | -719 | ||
| Other income | 1,815 | 497 | ||
| Change in fair value of investments | 0 | -4,074 | ||
| Gain on settlement of global cooling escrow | 0 | - | ||
| Total other income (expense), net | 4,521 | -4,296 | ||
| Loss from continuing operations before income tax expense (benefit) | -12,081 | -11,425 | ||
| Income tax expense (benefit) | 49 | -38 | ||
| Loss from continuing operations | -12,130 | -11,387 | ||
| Income (loss) from discontinued operations before income tax expense | 7,535 | -8,665 | ||
| Income tax expense | 0 | 132 | ||
| Income (loss) from discontinued operations | 7,535 | -8,797 | ||
| Net loss | -4,595 | -20,184 | ||
| Basic EPS | -0.09 | -0.44 | ||
| Diluted EPS | -0.1 | -0.44 | ||
| Basic Average Shares | 47,753,824 | 46,067,073 | ||
| Diluted Average Shares | 48,645,084 | 46,067,073 | ||
BIOLIFE SOLUTIONS INC (BLFS)
BIOLIFE SOLUTIONS INC (BLFS)